Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Mast cells and mastocytosis.

Metcalfe DD.

Blood. 2008 Aug 15;112(4):946-56. doi: 10.1182/blood-2007-11-078097. Review.

2.

Targeting c-kit in the therapy of mast cell disorders: current update.

El-Agamy DS.

Eur J Pharmacol. 2012 Sep 5;690(1-3):1-3. doi: 10.1016/j.ejphar.2012.06.030. Epub 2012 Jul 4. Review.

PMID:
22789565
3.

Mastocytosis.

Brockow K, Metcalfe DD.

Chem Immunol Allergy. 2010;95:110-24. doi: 10.1159/000315946. Epub 2010 Jun 1. Review.

4.

Recent advances in the understanding of mastocytosis: the role of KIT mutations.

Orfao A, Garcia-Montero AC, Sanchez L, Escribano L; REMA..

Br J Haematol. 2007 Jul;138(1):12-30. Review.

PMID:
17555444
5.

Mast cells and inflammation.

Frenzel L, Hermine O.

Joint Bone Spine. 2013 Mar;80(2):141-5. doi: 10.1016/j.jbspin.2012.08.013. Epub 2012 Oct 30. Review.

PMID:
23116710
6.

Systemic mastocytosis.

Robyn J, Metcalfe DD.

Adv Immunol. 2006;89:169-243. Review.

PMID:
16682275
7.

Signal transduction and chemotaxis in mast cells.

Draber P, Halova I, Polakovicova I, Kawakami T.

Eur J Pharmacol. 2016 May 5;778:11-23. doi: 10.1016/j.ejphar.2015.02.057. Epub 2015 May 2. Review.

PMID:
25941081
8.

The tyrosine kinase network regulating mast cell activation.

Gilfillan AM, Rivera J.

Immunol Rev. 2009 Mar;228(1):149-69. doi: 10.1111/j.1600-065X.2008.00742.x. Review.

9.

Stinging Hymenoptera and mastocytosis.

Ruëff F, Dugas-Breit S, Przybilla B.

Curr Opin Allergy Clin Immunol. 2009 Aug;9(4):338-42. doi: 10.1097/ACI.0b013e32832d2bc7. Review.

PMID:
19474708
10.

The mast cell and allergic diseases: role in pathogenesis and implications for therapy.

Brown JM, Wilson TM, Metcalfe DD.

Clin Exp Allergy. 2008 Jan;38(1):4-18. Epub 2007 Nov 21. Review.

PMID:
18031566
11.

PIP3 regulation as promising targeted therapy of mast-cell-mediated diseases.

Shenker BJ, Ali H, Boesze-Battaglia K.

Curr Pharm Des. 2011 Nov;17(34):3815-22. Review.

PMID:
22103853
12.

Mastocytosis: advances in diagnosis and treatment.

Hungness SI, Akin C.

Curr Allergy Asthma Rep. 2007 Jul;7(4):248-54. Review.

PMID:
17547845
13.

The genetic basis of mast cell activation disease - looking through a glass darkly.

Molderings GJ.

Crit Rev Oncol Hematol. 2015 Feb;93(2):75-89. doi: 10.1016/j.critrevonc.2014.09.001. Epub 2014 Sep 28. Review.

PMID:
25305106
14.

Mast cell mediators in allergic inflammation and mastocytosis.

Castells M.

Immunol Allergy Clin North Am. 2006 Aug;26(3):465-85. Review.

PMID:
16931289
15.

Mast cells as targets of pimecrolimus.

Ma Z, Jiao Z.

Curr Pharm Des. 2011 Nov;17(34):3823-9. Review.

PMID:
22114844
16.

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM.

Leuk Res. 2001 Jul;25(7):603-25. Review.

PMID:
11377686
17.

Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders.

Gotlib J, Akin C.

Semin Hematol. 2012 Apr;49(2):128-37. doi: 10.1053/j.seminhematol.2012.01.007. Review.

PMID:
22449623
18.
19.

Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation.

Bai Y, Bandara G, Ching Chan E, Maric I, Simakova O, Bandara SN, Lu WP, Wise SC, Flynn DL, Metcalfe DD, Gilfillan AM, Wilson TM.

Leukemia. 2013 Feb;27(2):278-85. doi: 10.1038/leu.2012.218. Epub 2012 Jul 31. Review.

20.

The role of Th2 cytokines in mast cell homeostasis.

Shelburne CP, Ryan JJ.

Immunol Rev. 2001 Feb;179:82-93. Review.

PMID:
11292031

Supplemental Content

Support Center